Business Wire

CO-NEWMONT-CORP

14.4.2022 17:02:12 CEST | Business Wire | Press release

Share
Newmont Publishes 2021 Sustainability Report

Today, Newmont Corporation (NYSE: NEM, TSX: NGT) launched its 2021 Sustainability Report as part of its suite of reports on the Company’s environmental, social and governance (ESG) practices in key areas that include health, safety and security, human rights, the environment, social acceptance, governance, and inclusion and diversity.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220414005599/en/

“Newmont has a long tradition of setting and transparently reporting against public targets. With this report, we offer stakeholders a clear and comprehensive understanding of our most material sustainability topics,” said Tom Palmer, Newmont President and CEO. “As the world’s leading gold company, our ESG practices are woven into the fabric of our company as we work to deliver on our purpose: to create value and improve lives through sustainable and responsible mining.”

Highlights of Newmont’s 2021 Sustainability Report:

  • Commitment to health and safety: Achieved zero work-related fatalities for the third year in a row. Further embedded our Fatality Risk Management program with a focus on verifying the critical controls that prevent fatalities and coaching frontline leaders to provide visible, felt leadership.
  • Response to COVID-19: Continued to put the health, safety and wellbeing of our workforce and host communities at the heart of every decision the Company made. Newmont strongly supported COVID-19 vaccines as they became available and adopted the position of requiring all employees and third-party workers to be fully vaccinated. With contributions through Newmont’s Global Community Support Fund, the Company supported COVID-19 testing facilities, vaccine awareness campaigns and vaccine rollouts in areas near our operations.
  • Sustainability-linked financial performance: Established the industry’s first sustainability-linked bond, holding Newmont to account for meeting our 2030 emissions reductions targets and to achieve gender parity in senior leadership roles by 2030. This represents the next step in aligning our business to our commitments and values by linking the interest rate payout to our performance on key ESG priorities.
  • Value sharing: Newmont played an important role in creating economic value in host communities and jurisdictions, contributing $10.8 billion to its workforce, host communities and jurisdictions through wages and benefits, operating costs, capital spend, royalties and taxes. This includes spending $1.4 billion with local and Indigenous suppliers, $21.9 million in community investments and providing ongoing opportunities for local and Indigenous employment, along with an additional $3.5 million from Newmont’s Global Community Support Fund.

Newmont’s sustainability efforts continue to be recognized by several leading independent organizations:

  • Recognized as a leading gold miner for the seventh consecutive year in the Dow Jones Sustainability Index (DJSI) while continuing to be ranked as the top mining company on FORTUNE’s list of the World’s Most Admired Companies;
  • Earned a rating of “AA” from MSCI, putting Newmont in the top quartile for precious metals and mining;
  • Listed as sixth overall and the top mining company in 3BL’s 100 Best Corporate Citizens;
  • Included in Bloomberg’s Gender-Equality Index (GEI) for Newmont’s efforts to advance women in the workplace for the fourth successive year;
  • Named to the JUST 100 as one of America’s most JUST companies by JUST Capital and CNBC, included in the JUST 100 and named Industry Leader for 2022; and
  • One of the most transparent companies in the S&P 500, according to Bloomberg’s ESG Disclosure Score.

Newmont’s 2021 Sustainability Report is written in accordance with the GRI 2016 Universal Standards Core option, the GRI Mining and Metals Sector Supplement, the Sustainability Accounting Standards Board (SASB) Metals and Mining standards and is externally assured by an independent third-party. Additionally, Newmont’s sustainability report aligns with ICMM’s Mining Principles’ Performance Expectations and the World Gold Council’s Responsible Gold Mining Principles.

The full 2021 Sustainability Report, along with the ESG data tables and comprehensive GRI and SASB content indices, is available for download on Newmont’s website .

About Newmont

Newmont is the world’s leading gold company and a producer of copper, silver, zinc and lead. The Company’s world-class portfolio of assets, prospects and talent is anchored in favorable mining jurisdictions in North America, South America, Australia and Africa. Newmont is the only gold producer listed in the S&P 500 Index and is widely recognized for its principled environmental, social and governance practices. The Company is an industry leader in value creation, supported by robust safety standards, superior execution and technical expertise. Newmont was founded in 1921 and has been publicly traded since 1925.

At Newmont, our purpose is to create value and improve lives through sustainable and responsible mining. To learn more about Newmont’s sustainability strategy and initiatives, go to www.newmont.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye